Advertisement

The Role of Epstein-Barr Virus in Burkitt’s Lymphoma

  • H. zur Hausen
Part of the NATO Advanced Science Institutes Series book series (NSSA, volume 57)

Abstract

The pathogenesis of Epstein-Barr virus (EBV) infections has been analyzed extensively in recent years. In particular, the virus latency of this agent can be approached experimentally: it is the only one of the human herpes viruses that permits the establishment of latent infections under tissue culture conditions, thus facilitating studies of the mode of regulation of viral genome persistence.

Keywords

Lymphoblastoid Line Oncogenic Agent Tious Mononucleosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brade, L., Müller-Lantzsch, N., and zur Hausen, H. B-lymphotropic papovavirus and possibility of infections in humans. J. Med. Virol. 6, 301–308, 1980.CrossRefGoogle Scholar
  2. Brade, L., Vogl, W., Gissmann, L., and zur Hausen, H. Propagation of B-lymphotropic papovavirus (LPV) in human B-lymphoma cells and characterization of its DNA. Virology 114, 228–235, 1981.CrossRefGoogle Scholar
  3. de Thé, G., Geser, A., Day, N.E., Tukei, P.M., Williams, E.H., Beri, D.P., Smith, P.G., Dean, A.G., Bornkamm, G.W., Feorino, P., and Henle, W. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt’s lymphoma from Ugandan prospective study. Nature 274, 756–761, 1978.CrossRefGoogle Scholar
  4. Diehl, V., Krause, P., Hellriegel, K.P., Busche, M., Schedel, I., and Laskewitz, E. In: Immunological Diagnosis of Leukemias and Lymphomas. Thierfelder, T., Rodt, H., and Thiel, E. (eds.). Springer-Verlag, Berlin and New York, pp. 289–296, 1977.CrossRefGoogle Scholar
  5. Epstein, M.A., Achong, B.G., and Barr, Y.M. Virus particles in cultured lymphoblasts from Burkitt1s lymphoma. Lancet I, 702–703, 1964.Google Scholar
  6. Epstein, M.A., Hunt, R.D., and Rabin, H. Pilot experiments with EB virus in owl monkeys (Aotus trivirgatus). I. Reticulo-proliferative disease in an inoculated animal. Int. J. Cancer 12, 309–318, 1973.CrossRefGoogle Scholar
  7. Henle, W., and Henle, G. Epstein-Barr virus: the cause of infectious mononucleosis — a review. In: Oncogenesis and Herpesviruses. Biggs, P.M., de Thé, G., and Payne, L.N. (eds.), IARC, Lyon, pp. 269–274, 1972.Google Scholar
  8. Henle, W., Diehl, V., Kohn, G., zur Hausen, H., and Henle, G. Herpes-type virus and chromosome markers in normal leukocytes after growth with irradiated Burkitt cells. Science 157, 1064, 1065, 1967.Google Scholar
  9. Henle, G., Henle, W., and Diehl, V. Relation of Burkitt’s tumor associated herpes-type virus to infectious mononucleosis. Proc. Nat. Acad. Sci. U.S. 59, 94–101, 1968.CrossRefGoogle Scholar
  10. Henle, G., Henle, W., Klein, G., Gunvén, P., Clifford, P., Morrow, R.H., and Ziegler, J.L. Antibodies to early Epstein-Barr virus-induced antigens in Burkitt’s lymphoma. J. Natl. Cancer Inst. 46, 861–871, 1971.Google Scholar
  11. Henle, W., Henle, G., Gunvén, P., Klein, G., Clifford, P., and Singh, S. Patterns of antibodies to Epstein-Barr virus- induced early antigens in Burkitt’s lymphoma. Comparison of dying patients with long-term survivors. J. Natl. Cancer Inst. 50, 1163–1173, 1973.Google Scholar
  12. Ito, Y., Kishihita, M., Morigaki, T., Yanase, S., and Hirayama, T. Induction and intervention of Epstein-Barr virus antigens in human lymphoblastoid cell lines: a simulation model for study of cause and prevention of nasopharyngeal carcinoma and Burkitt’s lymphoma. In: Nasopharyngeal Carcinoma: Basic Research as Applied to Diagnosis and Therapy, Gustav-Fischer Verlag, Stuttgart, New York, 1980.Google Scholar
  13. Lindahl, T., and Adam, A. Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line. J. Mol. Biol. 102, 511–530, 1976.CrossRefGoogle Scholar
  14. Manolov, G., and Manolova, Y. Marker band in one chromosome 14 from Burkitt lymphomas. Nature 237, 33–34, 1972.CrossRefGoogle Scholar
  15. Nilsson, K., Giovanella, B.C., Stehlin, J.S., and Klein, G. Tumorigenicity of human hematopoietic cell lines in athymic nude mice. Int. J. Cancer 19, 337–344, 1977.CrossRefGoogle Scholar
  16. Nonoyama, M., and Pagano, J.S. Detection of Epstein-Barr viral genome in non-productive cells. Nature (New Biol.) 233, 103–106, 1971.CrossRefGoogle Scholar
  17. Pope, J.H., Hörne, M.K., and Scott, W. Transformation of foetal human leukocytes in vitro by filtrates of a human leukemic cell line containing herpes-like virus. Int. J. Cancer 3, 857–866, 1969.CrossRefGoogle Scholar
  18. Purtillo, D.T., DeFlorio, D., Hütt, L.M., Bhawan, J., Yang, J.P.S., Otto, R., and Edwards, W. Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome. New Engl. J. Med. 297, 1077–1081, 1977.CrossRefGoogle Scholar
  19. Reedman, B.M., and Klein, G. Cellular localization of an Epstein- Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int. J. Cancer 11, 499–520, 1973.CrossRefGoogle Scholar
  20. Shope, T., Dechario, D., and Miller, G. Malignant lymphoma in >cottontop marmosets after inoculation with Epstein-Barr virus. Proc. Natl. Acad. Sci. U.S. 70, 2487–2491, 1973.CrossRefGoogle Scholar
  21. Yamamoto, N., Bister, K., and zur Hausen, H. Retinoic acid inhibition of Epstein-Barr virus induction. Nature 278, 553–554, 1979.CrossRefGoogle Scholar
  22. Yamamoto, N., Müller-Lantzsch, N., and zur Hausen, H. Differential inhibition of Epstein-Barr virus induction by the amino acid analogue, L-canavanine. Int. J. Cancer 25, 439–443, 1980a.CrossRefGoogle Scholar
  23. Yamamoto, N., Müller-Lantzsch, N., and zur Hausen, H. Effect of actinomycin D and cycloheximide on Epstein-Barr virus induc¬tion in lymphoblastoid cells. J. Gen. Virol. 51, 235–261, 1980b.CrossRefGoogle Scholar
  24. zur Hausen, H. DNA viruses in human cancer: biochemical approaches. Cancer Res. 36, 414–416, 1976.Google Scholar
  25. zur Hausen, H. The role of viruses in human tumors. Adv. Cancer Res. 33, 77–107, 1980a.CrossRefGoogle Scholar
  26. zur Hausen, H. The role of Epstein-Barr virus in Burkitt’s lymphoma and nasopharyngeal carcinoma. In: Oncogenic Herpes-viruses. Rapp, F. (ed.), CRC Press, Boca Raton, Florida. Vol. II, pp. 13–24, 1980b.Google Scholar
  27. zur Hausen, H., and Gissmann, L. Lymphotropic papovavirus isolated from African green monkey and human cells. Med. Microbiol. Immunol. 167, 137–153, 1979.CrossRefGoogle Scholar
  28. zur Hausen, H., Schulte-Holthausen, H., Klein, G., Henle, W., Henle, G., Clifford, P., and Santesson, L. EBV-DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228, 1056–1058, 1970.CrossRefGoogle Scholar
  29. zur Hausen, H., O’Neill, F.J., Freese, U.K., and Hecker, E. Persisting oncogenic herpesvirus induced by the tumor promoter TPA, Nature 272, 373–375, 1978.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • H. zur Hausen
    • 1
  1. 1.Institut für VirologieZentrum für Hygiene Universität FreiburgFreiburgWest Germany

Personalised recommendations